Kalpana Kalpana (Editor)

ATC code L04

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit

ATC code L04 Immunosuppressants is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup L04 is part of the anatomical group L Antineoplastic and immunomodulating agents.

Contents

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL04.

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

L04AA Selective immunosuppressants

L04AA02 Muromonab-CD3 L04AA03 Antilymphocyte immunoglobulin (horse) L04AA04 Antithymocyte immunoglobulin (rabbit) L04AA06 Mycophenolic acid L04AA10 Sirolimus L04AA13 Leflunomide L04AA15 Alefacept L04AA18 Everolimus L04AA19 Gusperimus L04AA21 Efalizumab L04AA22 Abetimus L04AA23 Natalizumab L04AA24 Abatacept L04AA25 Eculizumab L04AA26 Belimumab L04AA27 Fingolimod L04AA28 Belatacept L04AA29 Tofacitinib L04AA31 Teriflunomide L04AA32 Apremilast L04AA33 Vedolizumab L04AA34 Alemtuzumab L04AA35 Begelomab L04AA36 Ocrelizumab L04AA37 Baricitinib

L04AB Tumor necrosis factor alpha (TNF-α) inhibitors

L04AB01 Etanercept L04AB02 Infliximab L04AB03 Afelimomab L04AB04 Adalimumab L04AB05 Certolizumab pegol L04AB06 Golimumab

L04AC Interleukin inhibitors

L04AC01 Daclizumab L04AC02 Basiliximab L04AC03 Anakinra L04AC04 Rilonacept L04AC05 Ustekinumab L04AC07 Tocilizumab L04AC08 Canakinumab L04AC09 Briakinumab L04AC10 Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab

L04AD Calcineurin inhibitors

L04AD01 Ciclosporin L04AD02 Tacrolimus L04AD03 Voclosporin

L04AX Other immunosuppressants

L04AX01 Azathioprine L04AX02 Thalidomide L04AX03 Methotrexate L04AX04 Lenalidomide L04AX05 Pirfenidone L04AX06 Pomalidomide

References

ATC code L04 Wikipedia